MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function
Ayaka Sugiura(Vanderbilt University Medical Center), Gabriela Andrejeva(Vanderbilt University Medical Center), Kelsey Voss(Vanderbilt University Medical Center), Darren R. Heintzman(Vanderbilt University Medical Center), Xincheng Xu(Cancer Research Institute), Matthew Z. Madden(Vanderbilt University Medical Center), Xiang Ye(Vanderbilt University Medical Center), Katherine L. Beier(Vanderbilt University Medical Center), Nowrin U. Chowdhury(Vanderbilt University Medical Center), Melissa M. Wolf(Vanderbilt University Medical Center), Arissa Young(Vanderbilt University Medical Center), Dalton Greenwood(Vanderbilt University Medical Center), Allison E. Sewell(Vanderbilt University Medical Center), Shailesh K. Shahi(University of Iowa), Samantha N. Freedman(University of Iowa), Alanna M. Cameron, Patrik Foerch, Tim Bourne, Juan Carlos García‐Cañaveras(Cancer Research Institute), John Karijolich(Vanderbilt University Medical Center), Dawn C. Newcomb(Vanderbilt University Medical Center), Ashutosh K. Mangalam(University of Iowa), Joshua D. Rabinowitz(Cancer Research Institute), Jeffrey C. Rathmell(Vanderbilt University Medical Center)
Cited by 208Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis